StrategIQ Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$274K Hold
950
0.03% 265
2023
Q3
$255K Sell
950
-98
-9% -$24.5K 0.03% 266
2023
Q2
$233K Sell
1,048
-10
-0.9% -$2.32K 0.03% 283
2023
Q1
$256K Sell
1,058
-25
-2% -$6.14K 0.03% 254
2022
Q4
$284K Sell
1,083
-25
-2% -$6.7K 0.03% 237
2022
Q3
$250K Sell
1,108
-15
-1% -$3.64K 0.03% 245
2022
Q2
$273K Sell
1,123
-50
-4% -$12.3K 0.03% 242
2022
Q1
$284K Hold
1,173
0.03% 259
2021
Q4
$264K Buy
1,173
+37
+3% +$7.81K 0.03% 258
2021
Q3
$242K Buy
1,136
+25
+2% +$5.75K 0.05% 201
2021
Q2
$271K Buy
+1,111
New +$273K 0.05% 185

Other funds holding AMGN

StrategIQ Financial Group's AMGN Position: Q4 2023 in Review

StrategIQ Financial Group held its Amgen (AMGN) position steady in Q4 2023 at 950 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #265.

StrategIQ Financial Group first reported a position in AMGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $284K in Q4 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • StrategIQ Financial Group held 950 shares of Amgen worth $274K as of Q4 2023.
  • StrategIQ Financial Group left its Amgen share count unchanged in Q4 2023.
  • Amgen made up 0.03% of StrategIQ Financial Group's portfolio in Q4 2023, its #265 holding.
  • StrategIQ Financial Group first reported a position in Amgen in Q2 2021 and has held it in 11 quarters since.
  • StrategIQ Financial Group's Amgen position peaked at $284K in Q4 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.